RU  UA  EN

Monday, 25 November

10:23
Pfizer announced positive topline results from pivotal trial of Covid-19 vaccine for children
Pfizer Inc. and BioNTech SE, on Monday, September 20, announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children 5 to 11 years of age using a two-dose regimen of 10 µg administered 21 days apart, a smaller dose than the 30 µg dose used for people 12 and older.

07:35
Ukraine is imposing stricter quarantine measures amid the new Covid-19 surge
According to the new resolution of Ukraine's Cabinet of Ministers, the country imposes stricter quarantine measures effective from September 20.

12:26
BioNTech to seek approval for Covid jabs for younger children
The German company BioNTech, which developed the Pfizer vaccine, expects to seek approval from regulators for Covid jabs suited for younger children as early as mid-October, its founders have said.

16:32
Pfizer has launched new trials of oral COVID-19 drugs
Pfizer Inc and Merck & Co Inc announced on Wednesday new trials of their experimental oral antiviral drugs for COVID-19 as the race to develop an easy-to-administer treatment for the potentially fatal illness heats up, Reuters reports.

15:56
Israel becomes the first country in the world to give COVID boosters to a broad slice of population
The Health Ministry on Tuesday announced that Israelis age 30 and over are now eligible to receive a COVID-19 vaccine booster, expanding the program days after lowering the minimum age to 40.

20:39
Pfizer data suggests third dose of Covid-19 vaccine 'strongly' boosts protection against the Delta variant
A third dose of the Pfizer/BioNTech Covid-19 vaccine can "strongly" boost protection against the Delta variant -- beyond the protection afforded by the standard two doses, new data released by Pfizer on Wednesday suggests.